Skip to content
Opioid Prescriber Education Program
ACCME, ACPE, ADA/CERP contact hours:
4.0 or 0.40 CEUs
Thank you for taking the time to evaluate this continuing education activity. Your assistance in this evaluation process is invaluable in helping us assess your needs and to improve our programs.
To assure anonymity, your name is NOT required.
1.
Please select profession type:
Physician
Dentist
Physician Assistant
Nurse Practitioner
Medical Resident
Pharmacist
Pharmacy Technician
Pharmacy Resident/Fellow
Student
Other (please specify)
2.
Law: Please rate your agreement that the following objectives were met.
Strongly Agree
Agree
Neither Agree nor Disagree
Disagree
Strongly Disagree
List the Federal and New York State (NYS) requirements for prescribing controlled substances
Strongly Agree
Agree
Neither Agree nor Disagree
Disagree
Strongly Disagree
Define the NYS Prescription Monitoring Program (PMP) and its purpose
Strongly Agree
Agree
Neither Agree nor Disagree
Disagree
Strongly Disagree
Describe NYS 7-day rules
Strongly Agree
Agree
Neither Agree nor Disagree
Disagree
Strongly Disagree
3.
Pain management: Please rate your agreement that the following objectives were met.
Strongly Agree
Agree
Neither Agree nor Disagree
Disagree
Strongly Disagree
Describe the pathophysiology and general approaches for pain assessment in the ambulatory setting
Strongly Agree
Agree
Neither Agree nor Disagree
Disagree
Strongly Disagree
Describe approaches for managing acute pain and how they differ from approaches for managing chronic pain
Strongly Agree
Agree
Neither Agree nor Disagree
Disagree
Strongly Disagree
Outline evidence-based best practices for appropriate prescribing of opioid analgesics
Strongly Agree
Agree
Neither Agree nor Disagree
Disagree
Strongly Disagree
4.
Opioid use disorder (OUD): Please rate your agreement that the following objectives were met.
Strongly Agree
Agree
Neither Agree nor Disagree
Disagree
Strongly Disagree
Identify risk factors for the development of OUD
Strongly Agree
Agree
Neither Agree nor Disagree
Disagree
Strongly Disagree
Describe screening tools and processes that may be used to identify signs of OUD
Strongly Agree
Agree
Neither Agree nor Disagree
Disagree
Strongly Disagree
Describe strategies to mitigate the risk of iatrogenic OUD
Strongly Agree
Agree
Neither Agree nor Disagree
Disagree
Strongly Disagree
Discuss treatment approaches based on whether the patient has chronic pain, OUD, both, or neither
Strongly Agree
Agree
Neither Agree nor Disagree
Disagree
Strongly Disagree
Explain harm reduction strategies
Strongly Agree
Agree
Neither Agree nor Disagree
Disagree
Strongly Disagree
5.
Palliative care: Please rate your agreement that the following objectives were met.
Strongly Agree
Agree
Neither Agree nor Disagree
Disagree
Strongly Disagree
Outline principles of and differences between palliative care and hospice care
Strongly Agree
Agree
Neither Agree nor Disagree
Disagree
Strongly Disagree
Describe the use of opioids in hospice and palliative care (e.g., cancer pain, dyspnea, methadone)
Strongly Agree
Agree
Neither Agree nor Disagree
Disagree
Strongly Disagree
6.
Please rate program content:
Strongly Agree
Agree
Neither Agree nor Disagree
Disagree
Strongly Disagree
The content was current
Strongly Agree
Agree
Neither Agree nor Disagree
Disagree
Strongly Disagree
My knowledge of the subject was improved
Strongly Agree
Agree
Neither Agree nor Disagree
Disagree
Strongly Disagree
The educational material was well organized
Strongly Agree
Agree
Neither Agree nor Disagree
Disagree
Strongly Disagree
7.
Please rate the presentation by Karl D. Fiebelkorn, BSPharm, RPh, MBA:
Strongly Agree
Agree
Neither Agree nor Disagree
Disagree
Strongly Disagree
The presenter demonstrated topic mastery
Strongly Agree
Agree
Neither Agree nor Disagree
Disagree
Strongly Disagree
The speaker moved through the subject material at a reasonable pace
Strongly Agree
Agree
Neither Agree nor Disagree
Disagree
Strongly Disagree
8.
Please rate the presentation by Romanth Waghmarae, MD, DABA, FACIP, FIPP:
Strongly Agree
Agree
Neither Agree nor Disagree
Disagree
Strongly Disagree
The presenter demonstrated topic mastery
Strongly Agree
Agree
Neither Agree nor Disagree
Disagree
Strongly Disagree
The speaker moved through the subject material at a reasonable pace
Strongly Agree
Agree
Neither Agree nor Disagree
Disagree
Strongly Disagree
9.
Please rate the presentation by Arthur Weissman, MD, FASAM:
Strongly Agree
Agree
Neither Agree nor Disagree
Disagree
Strongly Disagree
The presenter demonstrated topic mastery
Strongly Agree
Agree
Neither Agree nor Disagree
Disagree
Strongly Disagree
The speaker moved through the subject material at a reasonable pace
Strongly Agree
Agree
Neither Agree nor Disagree
Disagree
Strongly Disagree
10.
Please rate the presentation by Robert G. Wahler, Jr., PharmD, CPE:
Strongly Agree
Agree
Neither Agree nor Disagree
Disagree
Strongly Disagree
The presenter demonstrated topic mastery
Strongly Agree
Agree
Neither Agree nor Disagree
Disagree
Strongly Disagree
The speaker moved through the subject material at a reasonable pace
Strongly Agree
Agree
Neither Agree nor Disagree
Disagree
Strongly Disagree
11.
Please rate the pre- and post-test assessment:
Strongly Agree
Agree
Neither Agree nor Disagree
Disagree
Strongly Disagree
The pre- and post-test questions helped me assess my learning
Strongly Agree
Agree
Neither Agree nor Disagree
Disagree
Strongly Disagree
The pre- and post-test questions were well administered
Strongly Agree
Agree
Neither Agree nor Disagree
Disagree
Strongly Disagree
12.
Please rate the online delivery elements:
Strongly Agree
Agree
Neither Agree nor Disagree
Disagree
Strongly Disagree
The instructions for the registration process were clear
Strongly Agree
Agree
Neither Agree nor Disagree
Disagree
Strongly Disagree
The website was easy to navigate
Strongly Agree
Agree
Neither Agree nor Disagree
Disagree
Strongly Disagree
The audio was of good quality
Strongly Agree
Agree
Neither Agree nor Disagree
Disagree
Strongly Disagree
The video was of good quality
Strongly Agree
Agree
Neither Agree nor Disagree
Disagree
Strongly Disagree
13.
Based on information presented in the program I will:
Change my practice
Seek additional information on the topic
Make no changes as the content supports my current practice
If you disagree or answer "No" to the following question, please give support for your answer. An explanation is imperative for the Office of Continuing Pharmacy Education to properly evaluate your feedback.
14.
The program was objective, scientifically based, and free of commercial bias:
Yes
No
15.
If you disagree, please be specific in your explanation:
16.
Which of the following course features attracted you to this program?
Free of charge
Interprofessional expert presenters
Online self-paced format
CE accreditation applicable to my practice
Comments:
17.
Please list any additional comments regarding this educational activity:
18.
Please list future topics you would like to see:
19.
How did you hear about this program?
New York State Department of Health
University at Buffalo Continuing Education office
Employer
Professional organization
Internet search
Colleague
Other (please specify)
Evaluation information is a requirement of CE accreditation. Thank you for taking the time to complete this evaluation. Your comments will be used to assist us in improving the quality of future CE activities.